Back to Screener

Healthcare

Oryzon Genomics S.A.(ORYZF)

Live Price

Offline

$3.65

+0.00% today

1Y Change

+13.20%

Window

Jun 26, 2025 β†’ Jun 24, 2026

Market Cap
$220.00M
Revenue Growth
-100.0%
EPS Growth
+38.2%
Dividend Yield
0.0%

Coverage: 252 bars Β· Jun 26, 2025 β†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Oryzon Genomics S.A. (ORYZF) is a Healthcare stock with a market cap of $220.00M and listed on OTC. The stock last traded around $3.65 and up 13.2% across the available one-year price window (Jun 26, 2025 β†’ Jun 24, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +38.2%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +38.2%, free cash flow +82.0% with operating margin 0.0% and ROIC -3.2%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ORYZF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

ORYZF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

ORYZF

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

ORYZF Max Drawdown

-30.82%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ORYZF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedMay 18, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
May 18, 26
β€”
Est -0.05
β€”
β€”
Est β€”
β€”
May 18
β€”
Feb 27, 26
βœ“
-0.02
Est -0.04
+41.9%
β€”
Est 2231.6B
β€”
Feb 27
β€”
Nov 7, 25
βœ—
-0.01
Est -0.01
-1.0%
β€”
Est 1642.8B
β€”
Nov 7
β€”
May 12, 25
βœ“
-0.03
Est -0.03
+0.2%
β€”
Est β€”
β€”
May 12
β€”
Feb 24, 25
βœ“
-0.02
Est -0.03
+22.3%
β€”
Est 950.0B
β€”
Feb 24
β€”
Oct 24, 24
βœ—
-0.02
Est -0.02
-17.3%
835.1B
Est β€”
β€”
Oct 24
β€”
Jul 31, 24
βœ“
0.00
Est -0.01
+118.3%
4416.4B
Est β€”
β€”
Jul 31
β€”
May 6, 24
βœ“
-0.02
Est -0.03
+32.6%
β€”
Est β€”
β€”
May 6
β€”
Feb 26, 24
βœ“
-0.03
Est -0.06
+45.4%
β€”
Est β€”
β€”
Feb 26
β€”
Sep 30, 23
βœ“
-0.02
Est -0.04
+53.9%
β€”
Est β€”
β€”
Sep 30
β€”
Jun 30, 23
βœ“
0.02
Est -0.03
+166.6%
β€”
Est β€”
β€”
Jun 30
β€”
Mar 31, 23
βœ—
-0.03
Est -0.03
-3.5%
β€”
Est β€”
β€”
Mar 31
β€”
Feb 17, 23
βœ“
-0.04
Est -0.05
+20.0%
499.9B
Est β€”
β€”
Feb 17
β€”
Nov 2, 22
βœ“
-0.01
Est -0.05
+80.0%
β€”
Est β€”
β€”
Nov 2
β€”
Jul 22, 22
βœ“
0.01
Est 0.00
+130.4%
β€”
Est β€”
β€”
Jul 22
β€”
May 5, 22
βœ—
-0.03
Est -0.02
-31.8%
β€”
Est β€”
β€”
May 5
β€”
Feb 7, 22
βœ—
-0.04
Est -0.04
-2.4%
β€”
Est β€”
β€”
Feb 7
β€”
Oct 28, 21
βœ—
-0.02
Est -0.02
-3.8%
β€”
Est β€”
β€”
Oct 28
β€”
Jul 29, 21
βœ“
0.02
Est 0.01
+166.7%
β€”
Est β€”
β€”
Jul 29
β€”
May 7, 21
βœ—
-0.04
Est -0.02
-81.8%
β€”
Est β€”
β€”
May 7
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener